Predictive models and biomarkers for new drugs
A total of SEK 124, 2 million has been allocated for the programme Design, development and validation of new predictive models and new biomarkers necessary for development of new drugs. The programme time frame is 2010-2014.
The projects and the main applicants:
- Andersson, Dan - Strategies for antibiotic development to reduce resistance - Uppsala University
- Arnér, Elias - Sel-tagged protein ligands as new biomarkers in PET imaging - Karolinska Institutet
- Klareskog, Lars - PRedIctive Models in Inflammatory diseases (PRIMI study) - Karolinska Institutet
- Landegren, Ulf - Tools for diagnostics and drug development in cancer - Uppsala University
- Nilsson, Jan - Development of cardiovascular therapy targeting immunity - Lund University
- Perlmann, Thomas - Parkinson's disease models for translational research - Karolinska Institutet
- Svensson, Camilla - Chronic pain - from bench to bedside - Karolinska Institutet